This editorial from the LA Times updates readers on the ACLU v. Myriad gene patent lawsuit, for which arguments are scheduled to begin next week. "At stake is whether any human gene or test based on it can be covered by a patent," the editorial says, going on to support the ACLU side of the debate.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.